SK282755B6 - Soľ karboxamidhydrogenvínan, spôsob jej prípravy, farmaceutický prípravok s jej obsahom a jej použitie - Google Patents

Soľ karboxamidhydrogenvínan, spôsob jej prípravy, farmaceutický prípravok s jej obsahom a jej použitie Download PDF

Info

Publication number
SK282755B6
SK282755B6 SK1594-99A SK159499A SK282755B6 SK 282755 B6 SK282755 B6 SK 282755B6 SK 159499 A SK159499 A SK 159499A SK 282755 B6 SK282755 B6 SK 282755B6
Authority
SK
Slovakia
Prior art keywords
tartrate
salt
benzopyran
fluoro
dihydro
Prior art date
Application number
SK1594-99A
Other languages
English (en)
Slovak (sk)
Other versions
SK159499A3 (en
Inventor
Hakan Nyqvist
Daniel D. Sohn
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of SK159499A3 publication Critical patent/SK159499A3/sk
Publication of SK282755B6 publication Critical patent/SK282755B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK1594-99A 1997-05-30 1998-05-15 Soľ karboxamidhydrogenvínan, spôsob jej prípravy, farmaceutický prípravok s jej obsahom a jej použitie SK282755B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702066A SE510305C2 (sv) 1997-05-30 1997-05-30 Nytt salt
PCT/SE1998/000907 WO1998054166A1 (en) 1997-05-30 1998-05-15 A new salt

Publications (2)

Publication Number Publication Date
SK159499A3 SK159499A3 (en) 2000-10-09
SK282755B6 true SK282755B6 (sk) 2002-12-03

Family

ID=20407187

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1594-99A SK282755B6 (sk) 1997-05-30 1998-05-15 Soľ karboxamidhydrogenvínan, spôsob jej prípravy, farmaceutický prípravok s jej obsahom a jej použitie

Country Status (34)

Country Link
US (2) US6858645B2 (ja)
EP (1) EP0984952B1 (ja)
JP (1) JP3554338B2 (ja)
KR (1) KR20010013127A (ja)
CN (1) CN1198814C (ja)
AR (1) AR012751A1 (ja)
AT (1) ATE228121T1 (ja)
AU (1) AU729301B2 (ja)
BG (1) BG64051B1 (ja)
BR (1) BR9809519A (ja)
CA (1) CA2291732C (ja)
DE (1) DE69809547T2 (ja)
DK (1) DK0984952T3 (ja)
EE (1) EE03874B1 (ja)
ES (1) ES2187030T3 (ja)
HK (1) HK1025575A1 (ja)
HU (1) HUP0001878A3 (ja)
ID (1) ID23794A (ja)
IL (1) IL133234A (ja)
IS (1) IS1943B (ja)
MY (1) MY117960A (ja)
NO (1) NO995853L (ja)
NZ (1) NZ501075A (ja)
PL (1) PL337181A1 (ja)
PT (1) PT984952E (ja)
RU (1) RU2193560C2 (ja)
SE (1) SE510305C2 (ja)
SK (1) SK282755B6 (ja)
TR (1) TR199902926T2 (ja)
TW (1) TW510899B (ja)
UA (1) UA53720C2 (ja)
WO (1) WO1998054166A1 (ja)
YU (1) YU62499A (ja)
ZA (1) ZA984486B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0102888D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102887D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102886D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0301796D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use II
SE0301795D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use I
EP2022110B1 (en) * 2006-05-11 2011-10-12 Johnson Controls Saft Advanced Power Solutions LLC Modular battery system
JP5163931B2 (ja) * 2007-03-08 2013-03-13 株式会社リコー 定着装置及び画像形成装置
EP2065385A1 (en) * 2007-11-28 2009-06-03 Laboratorios SALVAT, S.A. Stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester
CN103788043B (zh) * 2008-11-28 2016-02-03 中国医学科学院药物研究所 硝克柳胺化合物晶iv型、其制法和其药物组合物与用途
JP6393310B2 (ja) * 2013-04-26 2018-09-19 サノフイＳａｎｏｆｉ ５−クロロ−チオフェン−２−カルボン酸［（ｓ）−２−［メチル−３−（２−オキソ−ピロリジン−１−イル）−ベンゼンスルホニルアミノ］−３−（４−メチル−ピペラジン−１−イル）−３−オキソ−プロプリル］アミドの酒石酸塩

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420151A (en) * 1989-12-22 1995-05-30 Aktiebolaget Astra Chroman derivatives
US5616610A (en) 1989-12-22 1997-04-01 Astra Aktiebolag (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans
IT1282705B1 (it) 1996-02-28 1998-03-31 Recordati Chem Pharm Uso di antagonisti del recettore serotoninergico 5-ht|a per il trattamento dell'incontinenza urinaria
US5990114A (en) 1996-02-28 1999-11-23 Recordati, S.A., Chemical And Pharmaceutical Company Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence

Also Published As

Publication number Publication date
HUP0001878A2 (hu) 2001-05-28
SE9702066L (sv) 1998-12-01
CN1198814C (zh) 2005-04-27
IS5270A (is) 1999-11-24
CA2291732C (en) 2003-12-30
NO995853D0 (no) 1999-11-29
IL133234A (en) 2004-05-12
JP3554338B2 (ja) 2004-08-18
UA53720C2 (uk) 2003-02-17
DK0984952T3 (da) 2003-02-24
PL337181A1 (en) 2000-08-14
EE9900549A (et) 2000-06-15
CN1258290A (zh) 2000-06-28
KR20010013127A (ko) 2001-02-26
HK1025575A1 (en) 2000-11-17
BG64051B1 (bg) 2003-11-28
AU729301B2 (en) 2001-02-01
EP0984952B1 (en) 2002-11-20
EP0984952A1 (en) 2000-03-15
ATE228121T1 (de) 2002-12-15
SK159499A3 (en) 2000-10-09
AU7792398A (en) 1998-12-30
NZ501075A (en) 2001-08-31
RU2193560C2 (ru) 2002-11-27
CA2291732A1 (en) 1998-12-03
US20030109576A1 (en) 2003-06-12
EE03874B1 (et) 2002-10-15
DE69809547D1 (de) 2003-01-02
IS1943B (is) 2004-08-13
NO995853L (no) 2000-01-31
YU62499A (sh) 2002-06-19
US20050085532A1 (en) 2005-04-21
ES2187030T3 (es) 2003-05-16
PT984952E (pt) 2003-03-31
TW510899B (en) 2002-11-21
TR199902926T2 (xx) 2000-03-21
ID23794A (id) 2000-05-11
DE69809547T2 (de) 2003-08-21
IL133234A0 (en) 2001-03-19
SE9702066D0 (sv) 1997-05-30
SE510305C2 (sv) 1999-05-10
MY117960A (en) 2004-08-30
BR9809519A (pt) 2000-06-20
WO1998054166A1 (en) 1998-12-03
BG103949A (en) 2000-07-31
AR012751A1 (es) 2000-11-08
ZA984486B (en) 1998-11-30
US6858645B2 (en) 2005-02-22
HUP0001878A3 (en) 2002-04-29
JP2002501527A (ja) 2002-01-15

Similar Documents

Publication Publication Date Title
JP5086069B2 (ja) 重硫酸アタザナビルおよび新規形態の製造方法
AU2005212229B2 (en) Modafinil compositions
EP3578546A1 (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
JP2008509953A (ja) ４−［［（７ｒ）−８−シクロペンチル−７−エチル−５，６，７，８−テトラヒドロ−５−メチル−４−６−オキソ−２−ピペリジニル］アミノ］−３−メトキシ−ｎ−（１−メチル−４−ピペリジニル）ベンズアミドの水和物及び多形、その製造方法、並びにその薬物としての使用
SK282755B6 (sk) Soľ karboxamidhydrogenvínan, spôsob jej prípravy, farmaceutický prípravok s jej obsahom a jej použitie
AU2008235668A1 (en) Novel crystalline bepotastine metal salt hydrate, method for preparing same, and pharmaceutical composition comprising same
JP5959617B2 (ja) オタミキサバンの安息香酸塩
JP2023521985A (ja) Ｓ－ピンドロールの有機酸付加塩
EP2292213A1 (en) Compositions comprising a polymorphic form of armodafinil
KR101653816B1 (ko) 결정형 사포그릴레이트 옥살산염 일수화물 또는 이의 무수물
TWI835834B (zh) 製造(s)-n-(3-((2-((4-((1-乙醯基吡咯啶-3-基)(甲基)胺基)苯基)胺基)-5-甲氧基嘧啶-4-基)氧基)苯基)丙烯醯胺之方法及其調配物
KR100372964B1 (ko) 피페리딘유도체결정,이의제조용중간생성물및이의제조방법
MXPA99010942A (en) A new salt
CZ426199A3 (cs) Nová sůl
KR20110024057A (ko) 신규한 프라수그렐 황산수소염의 결정다형
JP2023161038A (ja) （ｓ）－ｎ－（３－（（２－（（４－（（１－アセチルピロリジン－３－イル）（メチル）アミノ）フェニル）アミノ）－５－メトキシピリミジン－４－イル）オキシ）フェニル）アクリルアミドの製造のためのプロセスおよびその製剤
TW202216726A (zh) 八氫噻吩并喹啉化合物之琥珀酸鹽及其結晶
NZ548656A (en) A polymorph of R-(-)-modafinil, for use in treating sleep and other disorders